Navigation Links
Combination of Meniscus Allograft Transplantation and Repair of Articular Cartilage May Slow the Progression of Arthritis in the Knee
Date:7/7/2010

Stone Research Foundation Publishes Study Results in The British Journal of Bone & Joint Surgery, Showing a 9.9 Year Survival Rate. Success of Less Invasive Procedures for Knee Damage Could Help Lower Skyrocketing Instances of Knee Replacement Surgery

San Francisco, CA (PRWEB) July 7, 2010 -- Biologic knee repair, rather than bionic (artificial) replacement, may slow the progression of arthritis without limiting the option for future arthroplasty, according to a study by Kevin R. Stone, MD, chairman, the Stone Research Foundation in this month’s issue of The British Journal of Bone & Joint Surgery. These research results could have significant impact on the long-term feasibility of artificial knee replacement - the number of artificial joint replacement surgeries is predicted to increase to 3.4 million by 2030, with proportionate increases in cost. The goal of biologic knee repair, according to Dr. Stone, is to avoid or forestall knee replacement surgery.

The report is based on a study of 119 meniscal allograft transplantations performed concurrently with articular cartilage repair in 115 patients with severe articular cartilage damage. The Kaplan-Meier estimated mean survival time for the whole series was 9.9 years. Loss of the meniscus generates increased forces on the articular cartilage of the knee and other joint structures and increases the risk of the development of arthritis. The appropriate treatment for loss of the meniscus with unicompartmental arthritis remains controversial, with treatments including osteotomy, unicompartmental (UKR) or total knee replacement. The study was approved by an independent Institutional Review Board. The study abstract is available via The British Journal of Bone & Joint Surgery.

Co-authors of the study with Dr. Stone are Ann W. Walgenbach, RNNP; Wendy Adelson, MS; Jonathan Pelsis, MHP; and Tom Turek of The Stone Research Foundation, San Francisco.

About The Stone Research Foundation:
The Stone Research Foundation is an independent, public, non-profit research institute based in San Francisco. Its mission is to research and develop ways to prevent, treat, and reverse arthritis and joint injuries. More info is available at www.stoneresearch.org.

###

Read the full story at http://www.prweb.com/releases/2010/07/prweb4231024.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Combination MMRV vaccine linked with 2-fold risk of seizures
2. Noninvasive combination technique may reduce number of breast biopsies
3. New combination effective against pancreatic cancer
4. Combination treatment regimen not effective against advanced melanoma
5. Combination therapy targets stubborn leukemia stem cells
6. Hair Loss Doctor Overcomes Odds To Produce First Ever Combination Topical Hair Growth Formula
7. Combination antibiotics effective against chlamydia-induced arthritis
8. Leeza Gibbons and ZERONA Equals a Winning Combination
9. Researchers find new chemotherapy combination shows promise in endometrial cancer
10. Combination Treatment May Help Depressed Alcoholics
11. Combination therapy more effective for enlarged prostate
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Combination of Meniscus Allograft Transplantation and Repair of Articular Cartilage May Slow the Progression of Arthritis in the Knee 
(Date:6/28/2017)... , ... June 28, 2017 , ... ... is pleased to announce that a two year study conducted by the University ... Creek zeolite was successful in remediating potash brine-impacted groundwater. As a part of ...
(Date:6/27/2017)... ... June 27, 2017 , ... Excel Medical, the ... to the position of Executive Vice President, Sales and Marketing. Finnegan is a ... and medical device sales leadership. He has received industry recognition for innovations and ...
(Date:6/27/2017)... ... June 27, 2017 , ... The Congressional Budget Office (CBO) projects that ... the 2010 Patient Protection and Affordable Care Act (ACA), would result in 22 million ... under current law. , More than 20 million Americans have gained health insurance under ...
(Date:6/27/2017)... (PRWEB) , ... June 27, 2017 , ... ... management assistance and personal financial planning services to residents of southern New Hampshire, ... charity event that promises to fight hunger and homelessness in the region. , ...
(Date:6/27/2017)... ... June 27, 2017 , ... Hammer Strength, the world’s leading ... named Javair Gillett of the Houston Rockets the NBSCA Strength & Conditioning Coach of ... decided by NBSCA members who vote to select the coach who embodies the highest ...
Breaking Medicine News(10 mins):
(Date:6/27/2017)... , Jun 27, 2017   NuEyes (NuEyes ... of funding to fuel its growth in helping the legally ... (Osterhout Design Group), the leading developer of augmented, virtual ... technology sits. The undisclosed funding amount was provided ... firm, Arab Angel, with offices in Abu Dhabi ...
(Date:6/16/2017)... BOSTON , June 16, 2017  Exactly 50 years ... kicked off what later became known as the San Francisco ... www.northernlight.com ) is unveiling two radical innovations in strategic market ... summer.  This announcement marks the beginning of Northern Light,s "Summer ... ...
(Date:6/12/2017)... Inc., a biotechnology company focused on the development of novel ... and Head of Virology Kristin Bedard has been invited to ... Beyond meeting sponsored by Life Science Washington.  This Symposium ... PDT at the Agora Conference Center in Seattle, ... joined by other leaders in infectious disease research and the ...
Breaking Medicine Technology: